NFH
NVCR icon

NEXT Financial Holdings’s NovoCure NVCR Stock Holding History

NEXT Financial Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5K Buy
+100
New +$4.81K ﹤0.01% 1265

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NEXT Financial Holdings's NVCR Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in NovoCure (NVCR) in Q1 2019: 100 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1265 among its holdings.

200 funds tracked by Wall St. Rank hold NVCR as of Q1 2019.

  • NEXT Financial Holdings held 100 shares of NovoCure worth $5K as of Q1 2019.
  • NovoCure was a new NEXT Financial Holdings position in Q1 2019.
  • NovoCure made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1265 holding.
  • 200 funds tracked by Wall St. Rank held NovoCure as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.